Pathogenesis, diagnosis and monitoring of residual disease in acute promyelocytic leukaemia
Reiter A, Lengfelder E, Grimwade D. Pathogenesis, diagnosis and monitoring of residual disease in acute promyelocytic leukaemia. Acta Haematologica 2004;112:55-67.
A surrogate marker profile for PML/RARα expressing acute promyelocytic leukaemia and the association of immunophenotypic markers with morphological and molecular subtypes
Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, et al. A surrogate marker profile for PML/RARα expressing acute promyelocytic leukaemia and the association of immunophenotypic markers with morphological and molecular subtypes. Cytometry B Clin Cytom 2004;59B:1-9.
Immunofluoresent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia
Gomis F, Sanz J, Sempere A, Plume G, Senent ML, Perez ML, et al. Immunofluoresent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia. Ann Hematol 2004; 83:687-90.
Monocytic differentiation in acute myeloid leukaemia: A cause of Fc binding of monoclonal antibodies
Lawlor E, Finn T, Blaney C, Temperley IJ, McCann SR. Monocytic differentiation in acute myeloid leukaemia: a cause of Fc binding of monoclonal antibodies. Br J Haematol 1986; 64:339-46.
Direct evidence for a bone marrow origin of the alveolar macrophage in man
Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW. Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science 1976;192:1016-8.